SK

Sunil Kumar Jain

Director Director DIN 00722983
DIN 00722983 First appointment Feb 1995 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 1995
Shareholding value •••• Premium profile

About Sunil Kumar Jain

Data last updated:

Sunil Kumar Jain was a Director at Sunvij Drugs Private Limited (1995–2010) and Director at Volkaps Healthcare Limited (2009–2018). The companies operate in Pharma and Trading.

DIN 00722983
Primary Designation Director
Industry Pharma
First Appointment 03 Feb 1995

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sunvij Drugs Private Limited U24232GJ1995PTC077943
Director03 Feb 19951995₹24.23 Cr (FY 2024)Active
Volkaps Healthcare Limited U24232MP2009PLC022774
Director09 Dec 20092009₹78.7 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sunvij Drugs Private Limited
Volkaps Healthcare Limited
Premium access

Shareholding and investment profile for Sunil Kumar Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Kumar Jain

Sunil Kumar Jain was first appointed on 03 Feb 1995 as Director at Sunvij Drugs Private Limited. The most recent appointment on record is 09 Dec 2009 at Volkaps Healthcare Limited.

Sunil Kumar Jain held 2 earlier board appointments: Sunvij Drugs Private Limited (Director, 03 Feb 1995 to 13 Mar 2010); Volkaps Healthcare Limited (Director, 09 Dec 2009 to 25 May 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available